Nippon India ETF Nifty 50 Shariah BeES
Direct Plan · Nippon India Mutual Fund
Returns
Annualised (CAGR) returns for periods over a year.
Want to invest in this fund?
Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.
Rank in Category
| Period | This Fund | Category Avg. | Rank |
|---|---|---|---|
| 1W | +3.52% | +3.62% | 139 of 229 |
| 1M | +8.00% | +2.76% | 12 of 227 |
| 3M | -4.59% | -3.72% | 165 of 227 |
| 6M | -2.08% | -0.45% | 175 of 218 |
| YTD | -11.88% | -3.05% | 210 of 229 |
| 1Y | -8.02% | -0.32% | 185 of 193 |
| 2Y | -8.45% | +4.05% | 143 of 150 |
| 3Y | +1.95% | +11.19% | 120 of 125 |
| 5Y | +0.69% | +8.24% | 66 of 73 |
| 7Y | +8.17% | +11.66% | 47 of 56 |
| INCEPTION | +8.91% | — | — |
Ranked among: Exchange Traded Funds (ETFs) - Other ETF.
Rolling Returns
| Period | Average | Best | Worst | Positive Periods | Consistency |
|---|---|---|---|---|---|
| 3M | +2.65% | +31.58% | -25.97% | 62% | 24% |
| 6M | +5.13% | +54.25% | -24.93% | 60% | 24% |
| 1Y | +10.59% | +91.13% | -23.83% | 63% | 26% |
| 2Y | +10.36% | +51.63% | -15.88% | 83% | 35% |
| 3Y | +11.30% | +26.40% | -3.42% | 98% | 42% |
| 5Y | +11.85% | +19.93% | -1.91% | 98% | 43% |
| 7Y | +11.13% | +14.79% | +7.28% | 100% | 44% |
Rolling returns show the average, best and worst outcome an investor would have seen entering at any point in the window.
NAV History
AUM Trend (₹ Cr, quarterly average)
Expense Ratio Trend
Portfolio · Sep 2026
Asset Allocation
- Equity100.00%
- Debt0.00%
- Cash0.00%
- Other0.00%
Market Cap Split
- Large Cap93.66%
- Mid Cap6.10%
- Small Cap0.00%
- Others0.24%
Fundamentals
| Fund | Category | |
|---|---|---|
| P/E | 21.95 | — |
| P/B | 3.74 | — |
| Price / Sales | 2.02 | — |
| Price / Cash Flow | 15.94 | — |
| Dividend Yield (%) | 2.33 | — |
Holdings · Sep 2026
| Holding | Sector | Weight | Change (1M) |
|---|---|---|---|
| Infosys | IT - Software | 14.83% | -2.26% |
| Eternal | Retailing | 9.79% | — |
| Tata Consultancy Services | IT - Software | 8.84% | -1.69% |
| Sun Pharmaceutical | Pharmaceuticals & Biotechnology | 8.12% | -0.91% |
| Hindustan Unilever | Diversified FMCG | 7.04% | -0.46% |
| Hindalco Industries | Non - Ferrous Metals | 5.76% | -0.56% |
| UltraTech Cement | Cement & Cement Products | 5.47% | -0.35% |
| HCL Technologies | IT - Software | 5.47% | -0.47% |
| Asian Paints | Consumer Durables | 4.59% | -0.57% |
| Tech Mahindra | IT - Software | 4.09% | -0.35% |
| Nestle | Food Products | 3.97% | -0.64% |
| Oil & Natural Gas Corporation | Oil | 3.70% | -0.17% |
| Trent | Retailing | 3.68% | -0.44% |
| Cipla | Pharmaceuticals & Biotechnology | 3.20% | -0.21% |
| Dr Reddys Laboratories | Pharmaceuticals & Biotechnology | 3.18% | +0.16% |
View all 19 holdings
| Max Healthcare Institute | Equity | 2.92% | -0.41% |
| Tata Consumer Products | Agricultural Food & other Products | 2.61% | -0.29% |
| Tata Motors Passenger Vehicles | Automobiles | 2.50% | -0.27% |
| Net Current Assets | Equity | 0.24% | — |
Sector Allocation · Sep 2026
View all 13 sectors
Risk Metrics
Standard Deviation
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 14.37 | 16.71 | Low Volatility |
| 3Y | 13.63 | 15.13 | Low Volatility |
| 5Y | 14.31 | 14.14 | High Volatility |
What is this?
Annualized population standard deviation of daily denomination-adjusted NAV returns, multiplied by sqrt(252). Values require a full timeframe of NAV history.
Sharpe Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | -0.79 | -3.33 | Above Average |
| 3Y | -0.13 | -1.59 | Above Average |
| 5Y | -0.22 | -1.39 | Above Average |
What is this?
Annualized Sharpe ratio calculated from month-end NAV returns using the latest available FBIL Overnight MIBOR rate as the risk-free rate. For schemes with less than three years of history, the 3Y value uses since-inception data. Applied risk-free rate: 5.73% (published 2026-10-28).
Sortino Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | -0.71 | 0.07 | Below Average |
| 3Y | 0.31 | 2.33 | Below Average |
| 5Y | 0.17 | 1.11 | Below Average |
What is this?
Annualized from daily NAV returns using a 0.00% minimum acceptable return; downside deviation includes only returns below this target.
Compare With Peers
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
| Motilal Oswal Nasdaq Q50 ETF | +33.42% | +31.36% | — | +12.73% |
| Tata Silver Exchange Traded Fund | +26.44% | — | — | +39.36% |
|
SBI Silver ETF
Regular Plan · Growth
|
+26.42% | — | — | +34.10% |
| Kotak Silver ETF | +26.35% | +36.48% | — | +28.03% |
| ICICI PRUDENTIAL SILVER ETF | +26.35% | +36.57% | — | +24.10% |
| Edelweiss Silver ETF | +26.32% | — | — | +35.41% |
| Motilal Oswal Silver ETF | +26.09% | — | — | +46.27% |
|
Nippon India Silver ETF
Direct Plan
|
+26.05% | +36.23% | — | +25.08% |
|
HDFC Silver ETF
Growth Option
|
+25.77% | +36.06% | — | +34.08% |
|
Nippon India Nifty Pharma ETF
Direct Plan
|
+22.83% | +22.93% | +15.06% | +13.35% |
More From Nippon Life India Asset Management Limited
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
Nippon India Taiwan Equity Fund
Direct Plan · Growth Option
|
+61.78% | +49.40% | — | +24.96% |
|
Nippon India Silver ETF
Direct Plan
|
+26.05% | +36.23% | — | +25.08% |
|
Nippon India Silver ETF FOF
Direct Plan · IDCW Option
|
+24.99% | +35.38% | — | +24.09% |
|
Nippon India Nifty Pharma ETF
Direct Plan
|
+22.83% | +22.93% | +15.06% | +13.35% |
|
Nippon India Japan Equity Fund
Direct Plan · IDCW Option
|
+20.27% | +21.27% | +9.63% | +9.56% |
|
Nippon India ETF Gold BeES
Direct Plan
|
+16.58% | +30.82% | +23.10% | +15.30% |
|
Nippon India Gold Savings Fund
Direct Plan · Growth Option
|
+16.51% | +30.76% | +22.97% | +10.34% |
|
Nippon India US Equity Opportunities Fund
Direct Plan · IDCW Option
|
+11.90% | +18.73% | +10.93% | +14.93% |
|
Nippon India Pharma Fund
Direct Plan · Growth Option
|
+10.54% | +18.85% | +14.53% | +17.34% |
|
Nippon India Fixed Maturity Plan - XLV - Series 5
Direct Plan · Growth Option
|
+7.36% | +8.43% | — | +8.54% |
About This Scheme
Investment Objective
The investment objective of Nippon India ETF Nifty 50 Shariah BeES is to provide returns that, before expenses, closely correspond to the total returns of the Securities as represented by the Nifty50 Shariah Index by investing in Securities which are constituents of the Nifty50 Shariah Index in the same proportion as in the Index. Investors to note that Nippon India ETF Nifty 50 Shariah BeES is not a Shariah compliant scheme.There can be no assurance or guarantee that the investment objective of the Scheme will be achieved.
Stated Asset Allocation
Securities covered by the Nifty50 Shariah Index - 95% to 100%, Cash - 0% to 5%.
Exit Load
Nil
Fund Managers
Jitendra Tolani
Primary
Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.
GMP IPO Watch